Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 October 2024 | Story Precious Shamase | Photo Supplied
Sibahle Mabaso
Sibahle Mabaso during her BA (Hons) Drama and Theatre Arts (2022) graduation, which she passed cum laude.

Sibahle Mabaso, a talented and driven individual, has been making waves at the University of the Free State (UFS). As a runner-up in the prestigious Siyaphumelela ATD DREAM Scholar programme, Mabaso's dedication and achievements have not gone unnoticed.

A multi-faceted student, Mabaso excelled in both her academic pursuits and extracurricular activities. A graduate of the UFS Drama and Theatre Arts programme, Mabaso's academic pursuits have been as diverse as her interests. She has a BA in Drama and Theatre Arts (2019-2021), a BA Honours in Drama and Theatre Arts (2022), and she is currently pursuing a Master of Arts with specialisation in Gender Studies.  Her passion for the arts is evident in her work as a playwright, director, and educator. Mabaso is currently an Assistant Researcher in Transition, Development and Success within the Centre for Teaching and Learning.

Mabaso's journey to academic success has been marked by resilience and perseverance. Despite facing challenges, she has overcome obstacles through hard work, determination, and the support of mentors.

Beyond her academic achievements, Mabaso is committed to giving back to her community. She recently founded a creative enterprise called Wild Geese PTY LTD, which aims to provide opportunities for young creatives. Through her work, Mabaso hopes to inspire and mentor others, sharing her experiences and knowledge to help them reach their full potential.

As Mabaso continues her academic journey and pursues her career goals, her dedication and passion for both her studies and community engagement are sure to inspire others. Her achievements serve as a testament to the power of hard work, resilience, and a commitment to making a positive impact. Looking ahead, Mabaso hopes to continue her academic pursuits and pursue a career in higher education. She is also passionate about giving back to her community and mentoring young people. With her talent, dedication, and unwavering spirit, there is no doubt that Sibahle Mabaso will continue to achieve great things.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept